Delivery Order SPE2DB24D2102-SPE2DB26FJHMD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity, with a ceiling value of $1,867.39. This firm fixed-price delivery order has an ultimate completion date of October 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating it was competitively awarded among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets in a quantity of 90 units, with a firm fixed price ceiling value of $1,620.32. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a delivery order under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a quantity of 90-day supplies at a ceiling value of $18,287.44. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,851.36 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in a 90-count quantity. This competitively awarded, firm fixed-price contract is categorized as a delivery order with an ultimate completion date of September 17, 2025, and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $7,933.70 delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on October 24, 2025, with an ultimate completion date of October 27, 2025. This is a firm fixed price, non-set-aside contract with performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,683.45 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets in quantities of 90. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This award represents a routine...
- The Defense Logistics Agency awarded a $1,279.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Losartan-HCTZ 50-12.5 mg, a combination antihypertensive medication. The order was competitively awarded without a set-aside designation and is scheduled for completion by October 27, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) with a ceiling value of $14,821.90. This is a firm fixed price delivery order with no set-aside designation, meaning it was awarded through open competition. Performance will be completed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 25, 2025. This award is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Losartan-HCTZ 100-25 mg tablets in a 90-day quantity, valued at $8,843.11. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) valued at $9,377.10. This is a firm fixed price delivery order with no set-aside designation, reflecting competitive procurement for pharmaceutical supplies supporting military and federal healthcare systems. The contract requires completion by September 18, 2025, with performance at AmerisourceBergen's corporate office...
- SPE2DB24D2102Indefinite Delivery Contract
- SPE2DB24D2102-SPE2DB26FJHMDDelivery Order
The Defense Logistics Agency awarded a $12,889.64 delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of October 28, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company holds significant contracting relationships with the Defense Logistics Agency's Medical Supply Chain, delivering a wide range of pharmaceutical products and medical supplies to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for the antihypertensive medication Losartan-HCTZ represents routine pharmaceutical procurement through AmerisourceBergen's established contract vehicle, supporting ongoing federal medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 10/27/25 |